T8	Subject 20 45	a 52-year-old white woman
T10	Effect 60 98	a spontaneous nasal septal perforation
T11	Treatment 115 147	antiangiogenic drug, bevacizumab
T12	Age 22 33	52-year-old
T13	Race 34 39	white
T14	Gender 40 45	woman
T15	Drug 136 147	bevacizumab
T9	Adverse_event 50 59	developed
E1	Adverse_event:T9